@ShahidNShah
DTx Neuroglee raises $10 million to treat neurodegenerative diseases
A Boston-based startup is looking to help treat neurodegenerative disease with a smartphone-based digital therapeutic called Neuroglee.
This morning the startup got a boost when it closed a $10 million Series A round led by Openspace Ventures with participation from EDBI, Eisai Co and individual investors.
“Various techniques have been demonstrated to slow or improve cognitive impairment in Alzheimer’s disease,” Aniket Singh Rajput, CEO of Neuroglee, told MobiHealthNews in an email.
“While the majority of this work has been demonstrated in the hospital setting in inpatient programs, we had a dream of bringing that type of therapy to patients in their own homes – especially to those patients who aren’t near a clinical center of excellence with this type of program.
"We will now be able to do that by working with patients’ clinicians across the country via our virtual care and digital therapy solutions.”
Continue reading at mobihealthnews.com
Make faster decisions with community advice
- Chatbots in Healthcare: A More Humanized, Patient-Oriented Approach
- HIMSSCast: How documentation burdens patients and clinicians, and what can be done
- Spin-offs and Joint Ventures: Another way to Innovate with The Clinic by Cleveland Clinic
- 3 Tips to Help Discouraged Healthcare Startups Navigate the "Trough of Sorrow"
- 5 Must-Have Components in your Early Adoption Strategy
Next Article
-
HIMSSCast: How documentation burdens patients and clinicians, and what can be done
Augmedix CMO Dr. Davin Lundquist on the problems his company is trying to solve. The EHR revolutionized medical record-keeping, but it also created burdensome workflows that create barriers to …
Posted Sep 11, 2021 Clinical Documentation Improvement (CDI)